PRUDENCIO SAMSON: Open Payments
NPI 1013045863 · ROSEVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 28 payments from 7 companies in 2025. Trend: 2023 $1,075 · 2024 $1,035 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $330 |
| Alkermes, Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Cranial Technologies, Inc | 1 | $18 |
Products named: VRAYLAR, ARISTADA, CAPLYTA, ZENPEP, INGREZZA, Auvelity, Doc Band.
Industry payments across CA — which companies pay providers there.
